Previously treated cases tested for RR-/MDR-TB (%) in Guinea
Guinea: Previously treated cases tested for RR-/MDR-TB was 29.0% in 2024. ◆ Volatile
Latest (2024)
29.0%
Change on year
down 64.2%
World rank
161st
of 180 countries
All-time high
100.0%
in 2018
All-time low
0.0%
in 2008
Years of data
19
2005–2024
Previously treated cases tested for RR-/MDR-TB in Guinea, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Guinea recorded 29.0% for previously treated cases tested for rr-/mdr-tb in 2024.
The figure is down 64.2% on the previous year and down 23.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Guinea peaked at 100.0% in 2018 and was at its lowest, 0.0%, in 2008.
Guinea ranks 161st of 180 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 7.4% | — |
| 2006 | 5.7% | -23.0% |
| 2007 | 5.2% | -8.8% |
| 2008 | 0.0% | -100.0% |
| 2009 | 11.0% | — |
| 2010 | 4.0% | -63.6% |
| 2011 | 3.9% | -2.5% |
| 2013 | 12.0% | +207.7% |
| 2014 | 38.0% | +216.7% |
| 2015 | 36.0% | -5.3% |
| 2016 | 47.0% | +30.6% |
| 2017 | 72.0% | +53.2% |
| 2018 | 100.0% | +38.9% |
| 2019 | 100.0% | +0.0% |
| 2020 | 64.0% | -36.0% |
| 2021 | 100.0% | +56.2% |
| 2022 | 80.0% | -20.0% |
| 2023 | 81.0% | +1.2% |
| 2024 | 29.0% | -64.2% |
Guinea compared with similar countries
- Guinea's 29.0% is below the median for lower middle income countries, which is 90.0%, 32% of the median. (47 countries reporting)
- Guinea's 29.0% is below the median for Sub-Saharan Africa, which is 91.5%, 32% of the median. (46 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.9% | 0.0% | 11.0% | 5 |
| 2010s | 45.9% | 3.9% | 100.0% | 9 |
| 2020s | 70.8% | 29.0% | 100.0% | 5 |
Countries ranked near Guinea
- 158 Finland 33.0% compare
- 158 Niger 33.0% compare
- 160 Syria 32.0% compare
- 161 North Macedonia 29.0% compare
- 163 Trinidad and Tobago 27.0% compare
- 164 Mozambique 25.0% compare
More health data for Guinea
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8529 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,123 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11,190 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 113 (2025)
- Population ages 00-04, female, annual growth rate 0.9852 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0731 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9785 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Guinea?
- Previously treated cases tested for rr-/mdr-tb in Guinea was 29.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Guinea?
- The highest recorded value was 100.0% in 2018.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Guinea?
- The lowest recorded value was 0.0% in 2008.
- How does Guinea rank for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Guinea?
- Over the last ten years it is down 23.7%. The long-run trend across the full record is volatile.
- Where does this Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).